RESEARCH USE ONLY: All products are for laboratory research purposes only. Not for human or animal consumption.
By using this site, you confirm you are 21+ and acknowledge these products are not FDA approved.
GL
Grace L.
↻ Repeat Customer
13 days ago
Good packaging and consistent presentation compared to previous order.
DR
Daniel R.
✓ Verified Buyer
28 days ago
Arrived quickly and batch details were easy to verify. Will reorder.
Mechanism of Action
Tirzepatide is a first-in-class dual GIP and GLP-1 receptor agonist. The GIP component enhances beta-cell insulin secretion and promotes fat oxidation, while GLP-1 activation provides appetite suppression and glucose regulation. Exhibits biased agonism at both receptors for synergistic effects.
-
1
SURMOUNT-1: 22.5% mean weight loss at 15mg dose, 36.4% achieving >=25% weight loss
-
2
SURPASS-2: Superior to semaglutide 1mg for both HbA1c reduction and weight loss
-
3
SURPASS-4: Superior glycemic control vs insulin glargine with weight loss vs gain
-
4
Demonstrated improvements in blood pressure, lipids, and inflammatory markers
Jastreboff AM, Aronne LJ, et al.
— New England Journal of Medicine (2022)
Tirzepatide produced up to 22.5% weight reduction at 72 weeks (SURMOUNT-1)
Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes
PMID: 34170647
Frias JP, Davies MJ, et al.
— New England Journal of Medicine (2021)
Tirzepatide superior to semaglutide 1mg for HbA1c and weight loss (SURPASS-2)
Del Prato S, Kahn SE, et al.
— Lancet (2021)
Superior glycemic control vs insulin glargine with weight loss (SURPASS-4)
Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist
PMID: 32730231
Willard FS, Douros JD, et al.
— JCI Insight (2020)
Characterized biased agonism at both receptors explaining distinct pharmacological profile
Storage
Store lyophilized peptide at -20°C for long-term stability. Reconstituted solution should be stored at 2-8°C and used within 30 days. Avoid repeated freeze-thaw cycles.
Reconstitution
Reconstitute with bacteriostatic water (0.9% benzyl alcohol). Add solvent slowly down the side of the vial. Do not shake; gently swirl until dissolved.
Purity & Testing
Purity verified at ≥99.3% by HPLC. Each lot includes Certificate of Analysis with mass spectrometry confirmation and endotoxin testing.
Research Use Only
This product is intended for laboratory research purposes only. Not for human or animal consumption. Not FDA-approved for therapeutic use. Handle according to institutional biosafety protocols.
Frequently Asked Questions about Tirzepatide 15mg
What is Tirzepatide 15mg?
Tirzepatide 15mg (GLP-1/GIP Dual Agonist) is a research-grade peptide supplied at 15mg/vial with ≥99.30% HPLC-verified purity. Dual GLP-1/GIP agonist for advanced metabolic research.
What purity is your Tirzepatide 15mg?
Our Tirzepatide 15mg is verified at ≥99.30% purity by High-Performance Liquid Chromatography (HPLC). Each lot includes a Certificate of Analysis with mass spectrometry confirmation and endotoxin testing results.
How should I store Tirzepatide 15mg?
Store lyophilized Tirzepatide 15mg at -20°C for optimal long-term stability. After reconstitution with bacteriostatic water, store at 2-8°C and use within 30 days. Avoid repeated freeze-thaw cycles to maintain peptide integrity.
Do you offer bulk discounts on Tirzepatide 15mg?
Yes. We offer tiered pricing: 3-vial packs include a 7% discount and 5-vial packs include a 14% discount. All multi-vial options are available on this product page above.
Is Tirzepatide 15mg third-party tested?
Yes. Every batch of Tirzepatide 15mg is independently tested by third-party laboratories using HPLC and mass spectrometry. Certificate of Analysis available upon request. All products are manufactured under ISO-compliant conditions.
Related Metabolic Regulation & Energy Homeostasis Peptides